ABcann Global Corporation (TSX-V:ABCN) announces that Nobel Prize winner and the “Father of Marijuana Research,” Raphael Mechoulam has agreed to extend his role as an advisor to the Company.
ABcann Global Corporation (TSXV:ABCN) appoints W. Brett Wilson of Dragon’s Den fame to the Advisory Board of the Company in connection with the completion of the Company’s acquisition of ABcann Medicinals Inc. The Transaction included concurrent capital raises of $26.8 million to expand ABcann’s production capacity, which includes a $500,000 investment from Brett Wilson.
Canada is about to become the epicenter of one of the fastest growing and extremely profitable industries in the world: marijuana. Here’s why ABcann Global (TSX-V: ABCN) could become a global leader in the space.
Canada will become the first country among the G7 to legalize recreational use of cannabis, and will have a profound impact on legalization efforts around the world. Here’s a look at what to expect.
A lot of people believe the claims made for medical marijuana are a hoax. Just a fabrication designed to push for legalized recreational marijuana. But are they wrong? Here’s a look at why they’re wrong and what it means for Canada.
Weed stocks took a pounding over the last few weeks, with many stocks in the US and Canada saw single day declines of up to 15 per cent! Canadians share prices started to recover just days later, then dropped sharply once more, followed by a quick recovery. So, what the heck is going on with the cannabis industry?
The announcements by US Attorney General Jeff Sessions and White House Press Secretary Sean Spicer on a federal crackdown of recreational marijuana could have serious ramifications on stocks. Here’s a look at what could happen should Sessions get his way.
One of the biggest topics for 2017 is the legalization of marijuana in both the U.S. and Canada. While there are opposing views to this still controversial topic, perhaps we should be looking at one of the biggest benefits of legalizing marijuana: less blood on the streets.
The medical marijuana industry has been the hottest area of investment in Canada. Unfortunately, many investors are not looking at the most important metrics of the companies they are investing in: Cost of Goods Sold, or COGS.